About Axol Bioscience

We use iPSCs to build more relevant models of human disease to expand your understanding and de-risk drug development.

Axol Bioscience – building the next generation of more human-relevant in vitro models

Axol Bioscience is a leading provider of human induced pluripotent stem cell (iPSC) technologies, specializing in the manufacture of high-performance iPSC-derived cells and the delivery of industry-leading laboratory services. With over a decade of expertise, Axol partners with global pharmaceutical companies, contract research organizations (CROs), biotechnology firms, start-ups, and academic institutions to advance the use of iPSC-based models in drug discovery and disease research.

We operate across five key areas, neuroscience (including ALS, Alzheimer’s, Huntington’s, Parkinson’s, neuroinflammation), pain & sensation, ophthalmology (Dry-AMD, ophthal-inflammation), dermatology, and cardiovascular.

Axol offers scalable solutions including iPSC banking, reprogramming, gene editing, cell manufacturing, and quality control. The company is committed to closing the translational gap, developing physiologically relevant in vitro systems that improve consistency and relevance in human disease modeling and compound testing.

Axol is recognized for its scientific excellence, transparent collaboration, and rigorous quality standards, with manufacturing operations certified to ISO 9001:2015.

For all inquiries, contact operations@axolbio.com

We live and operate by our company values:

Performance, accountability, transparency, acting with integrity, diversity & inclusivity, and collaboration.

Focus areas:


Neuroscience	Neurodegenerative and neuroinflammatory diseases drug discovery
Cardiovascular	Cardiotoxicity and cardiac research
Ophthalmology	Loss of vision drug discovery
Pain & Sensation	Pain, sense and touch research
Dermatology	Skin + sensory cells